The Figure Summarizes the Results of the Study (IMAGE)
Caption
The antibodies present in the body after a previous infection or vaccination are less protective against infection with SARS-CoV-2 variants B.1.351 (South Africa) and P.1 (Brazil). The effect of antibodies already approved as drugs for Covid19 therapy also differs among SARS-CoV-2 variants.
Credit
Figure: Markus Hoffmann
Usage Restrictions
The use with reference to the source is free of charge and without permission in the context of editorial and scientific reporting about the Deutsches Primatenzentrum GmbH. Any other use, in particular for promotional and political purposes, requires prior approval.
License
Licensed content